SYNERGISTIC INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE DNA-POLYMERASE-ACTIVITY AND VIRUS-REPLICATION IN-VITRO BY COMBINATIONS OF CARBOXANILIDE NONNUCLEOSIDE COMPOUNDS

被引:26
作者
FLETCHER, RS
ARION, D
BORKOW, G
WAINBERG, MA
DMITRIENKO, GI
PARNIAK, MA
机构
[1] SIR MORTIMER B DAVIS JEWISH HOSP, LADY DAVIS INST MED RES, MONTREAL, PQ H3T 1E2, CANADA
[2] MCGILL UNIV, MCGILL AIDS CTR, MONTREAL, PQ H3T 1E2, CANADA
[3] UNIV WATERLOO, GUELPH WATERLOO CTR GRAD WORK CHEM, WATERLOO, ON N2L 3G1, CANADA
关键词
D O I
10.1021/bi00032a002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The carboxanilides UC84 and UC38 are nonnucleoside inhibitors of both the RNA-dependent and DNA-dependent DNA polymerase activities of HIV-1 reverse transcriptase (RT). We have previously shown that UC84 and UC38 bind to the same site as nevirapine but interact with different RT mechanistic forms, with UC84 preferentially binding to the RT-primer/template complex and UC38 binding only to the RT-primer/template-dNTP ternary complex [Fletcher, R. S., et al. (1995) Biochemistry 34, 4346-4353]. Here we demonstrate that combinations of UC84 and UC38 inhibit RT DNA polymerase activity in vitro in a synergistic manner. This synergy was noted primarily in reactions containing high concentrations of primer/template and K-m levels of dNTP substrate and was independent of both primer/ template identity and the molar ratio of UC84:UC38. Combination indices were in the range of 0.4-0.6, indicating substantial synergy in the inhibition of RT activity. More importantly, combinations of UC84 and UC38 also showed a high degree of synergy in inhibiting HIV-1 replication in both MT-4 and cord blood mononuclear cells, We believe this to be the first example of synergistic inhibition of HIV-1 RT by combinations of structurally related nonnucleoside inhibitors.
引用
收藏
页码:10106 / 10112
页数:7
相关论文
共 35 条
  • [1] ARTS EJ, 1994, J BIOL CHEM, V269, P14672
  • [2] OXATHIIN CARBOXANILIDE, A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS REPRODUCTION
    BADER, JP
    MCMAHON, JB
    SCHULTZ, RJ
    NARAYANAN, VL
    PIERCE, JB
    HARRISON, WA
    WEISLOW, OS
    MIDELFORT, CF
    STINSON, SF
    BOYD, MR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) : 6740 - 6744
  • [3] BALZARINI J, 1992, J BIOL CHEM, V267, P11831
  • [4] DIFFERENTIAL ANTIVIRAL ACTIVITY OF 2 TIBO DERIVATIVES AGAINST THE HUMAN IMMUNODEFICIENCY AND MURINE LEUKEMIA VIRUSES ALONE AND IN COMBINATION WITH OTHER ANTI-HIV AGENTS
    BUCKHEIT, RW
    GERMANYDECKER, J
    HOLLINGSHEAD, MG
    ALLEN, LB
    SHANNON, WM
    JANSSEN, PAJ
    CHIRIGOS, MA
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (11) : 1097 - 1106
  • [5] CHENG YC, 1987, J BIOL CHEM, V262, P2187
  • [6] QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS
    CHOU, TC
    TALALAY, P
    [J]. ADVANCES IN ENZYME REGULATION, 1984, 22 : 27 - 55
  • [7] ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS SYNERGISM BY ZIDOVUDINE (3'-AZIDOTHYMIDINE) AND DIDANOSINE (DIDEOXYINOSINE) CONTRASTS WITH THEIR ADDITIVE INHIBITION OF NORMAL HUMAN MARROW PROGENITOR CELLS
    DORNSIFE, RE
    STCLAIR, MH
    HUANG, AT
    PANELLA, TJ
    KOSZALKA, GW
    BURNS, CL
    AVERETT, DR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (02) : 322 - 328
  • [8] SYNERGISTIC INHIBITION OF REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, INCLUDING THAT OF A ZIDOVUDINE-RESISTANT ISOLATE, BY ZIDOVUDINE AND 2',3'-DIDEOXYCYTIDINE INVITRO
    ERON, JJ
    JOHNSON, VA
    MERRILL, DP
    CHOU, TC
    HIRSCH, MS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) : 1559 - 1562
  • [9] THE SAME MUTATION THAT ENCODES LOW-LEVEL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANCE TO 2',3'-DIDEOXYINOSINE AND 2',3'-DIDEOXYCYTIDINE CONFERS HIGH-LEVEL RESISTANCE TO THE (-) ENANTIOMER OF 2',3'-DIDEOXY-3'-THIACYTIDINE
    GAO, Q
    GU, ZX
    PARNIAK, MA
    CAMERON, J
    CAMMACK, N
    BOUCHER, C
    WAINBERG, MA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) : 1390 - 1392
  • [10] PYRIDINONE DERIVATIVES - SPECIFIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE INHIBITORS WITH ANTIVIRAL ACTIVITY
    GOLDMAN, ME
    NUNBERG, JH
    OBRIEN, JA
    QUINTERO, JC
    SCHLEIF, WA
    FREUND, KF
    GAUL, SL
    SAARI, WS
    WAI, JS
    HOFFMAN, JM
    ANDERSON, PS
    HUPE, DJ
    EMINI, EA
    STERN, AM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) : 6863 - 6867